Published on
Racemic Ketamine: How It Works and When It's Used
Racemic ketamine. S-ketamine. Esketamine. R-ketamine. Ketamine therapy keeps coming up in mental health conversations, but so does confusing terminology. What do these terms actually mean, and which one might help you?
The short answer: Racemic ketamine is the original, complete form of ketamine — a half-and-half mixture of two mirror-image molecules that work together. With over 50 years of medical use, it's the most studied form for mental health treatment.
This guide breaks down how racemic ketamine works, how it compares to esketamine (Spravato), and how it can be delivered in clinical settings or at home with telehealth oversight.
What Is Racemic Ketamine?
Racemic ketamine is ketamine's original formulation, containing equal parts of two mirror-image molecules called S-ketamine and R-ketamine. FDA-approved as an anesthetic in 1970, it has been used medically for over five decades. When people refer to "ketamine therapy" for mental health, they usually mean racemic ketamine.
Think of your left and right hands — mirror images with the same structure, but a left glove won't fit your right hand. S-ketamine and R-ketamine share this same relationship. "Racemic" is a chemistry term meaning equal parts of these mirror-image molecules, called enantiomers.
Here's what makes it different: Studies suggest racemic ketamine may provide broader therapeutic effects than isolated versions — potentially because each enantiomer contributes something different to the healing process.
How Does Racemic Ketamine Work in the Brain?
Traditional antidepressants slowly adjust neurotransmitter levels over weeks. Racemic ketamine works differently. It produces rapid changes in brain activity and synaptic function, with clinical effects often noticeable within 24 hours.
Depression doesn't just change how you feel. It changes how your brain cells communicate. Neural pathways that once fired easily become sluggish. Connections weaken. Racemic ketamine appears to reverse this through a four-stage cascade:
- Stage 1: Releasing the Brake. Ketamine blocks receptors on inhibitory brain cells, removing the "brake" that depression has placed on your neurons.
- Stage 2: The Glutamate Surge. With the brake released, your brain releases glutamate—the primary signal that gets neurons talking to each other. This targets the glutamate system, which handles about 40% of brain communication, rather than serotonin pathways.
- Stage 3: Growth Factor Release. The glutamate surge triggers production of BDNF (brain-derived neurotrophic factor)—essentially fertilizer for your brain. This activates pathways that build new proteins needed for brain cell growth and repair.
- Stage 4: New Connections Form. Your brain starts building again: new synaptic connections, stronger neural pathways, better communication between regions involved in mood regulation.
These synaptic changes persist for about 1-2 weeks after a single treatment, long after ketamine has left your system. Studies suggest racemic ketamine works by promoting synaptic plasticity and rebuilding neural connectivity, not just adjusting chemical levels.
Racemic Ketamine vs. S-Ketamine vs. Esketamine: What's the Difference?
Understanding ketamine terminology starts with the molecules themselves.
- S-ketamine is one of the two mirror-image molecules in ketamine. It binds more strongly to NMDA receptors than its counterpart, producing more potent anesthetic and dissociative effects at lower doses.
- Esketamine is simply the pharmaceutical name for S-ketamine. The brand name Spravato — a nasal spray FDA-approved for depression in 2019 — contains only this single molecule.
- Racemic ketamine contains both S-ketamine and R-ketamine in equal parts. This is ketamine's original formulation, used medically since 1970.
- R-ketamine is the other mirror-image molecule. Early research suggests it may offer longer-lasting antidepressant benefits with fewer side effects, working through different pathways than S-ketamine — including serotonin receptors and anti-inflammatory mechanisms.
What the research shows: Meta-analyses generally show racemic ketamine has greater response and remission rates than esketamine. The likely reason? You're receiving both molecular forms rather than just one — potentially benefiting from R-ketamine's distinct therapeutic mechanisms.
So which one is right for you? Neither option is universally "better." Esketamine offers FDA approval and potential insurance coverage but requires facility-based treatment with mandatory monitoring. Racemic ketamine shows stronger efficacy in head-to-head comparisons and offers more flexible administration options, including at-home sublingual treatment.
Racemic Ketamine vs. Esketamine: Compared
When Is Racemic Ketamine Used?
Racemic ketamine has the strongest evidence for treatment-resistant depression and reducing suicidal ideation.
Treatment-Resistant Depression
This is where racemic ketamine shines. If you've tried multiple antidepressants without success, systematic reviews show that ketamine can improve depression severity within about 24 hours compared to a placebo. For people who've spent years cycling through medications, that timeline can feel like a breakthrough.
Acute Suicidal Ideation
When someone needs rapid intervention for suicidal thoughts, ketamine's fast-acting timeline becomes critical—making it valuable for crisis intervention where waiting weeks isn't safe.
Bipolar Depression
Traditional antidepressants risk triggering manic episodes in bipolar disorder. Racemic ketamine has shown antidepressant effects in both unipolar and bipolar depression, though it's still used alongside mood-stabilizing strategies.
Treatment-Resistant OCD
Preliminary controlled trials show short-term symptom reductions, though the evidence is still early.
A Note on PTSD
Evidence for ketamine as a standalone treatment for PTSD is mixed. However, when combined with trauma-focused therapy like EMDR, some patients find that ketamine helps them access and process difficult material.
How Is Racemic Ketamine Administered?
The method of administration affects your treatment experience, safety requirements, and accessibility. Here's what to expect from each approach.
Sublingual At-Home Treatment
Prospective studies suggest that at-home sublingual ketamine with telehealth oversight can be safe and effective for many people with moderate to severe anxiety and depression. You take the medication in your own space, with a licensed clinician guiding the experience remotely.
IV Infusion
The standard protocol involves 0.5 mg/kg administered over 40 minutes in clinical settings. This has the strongest evidence base but requires clinic visits and continuous monitoring.
Intramuscular Injection
Simpler administration without infusion equipment, used clinically since the 1970s. Still requires clinical supervision but can be delivered in outpatient settings.
Safety Across All Methods
All routes require careful screening and medical oversight, including cardiovascular monitoring appropriate to the setting.
For a detailed comparison, see our guide on at-home vs. infusion ketamine therapy.
The Innerwell Approach to Racemic Ketamine Therapy
If you've read this far, you're probably wondering what treatment actually looks like—and whether you can access it without rearranging your life around clinic visits.
Innerwell delivers racemic ketamine therapy through licensed psychotherapists, not unlicensed guides. Patients receive sublingual treatment at home with comprehensive clinical oversight.
What makes this approach different:
- Licensed clinicians. Every session is overseen by Master's or Doctoral-level licensed therapists with specialized training in ketamine-assisted therapy.
- Therapeutic support built in. Many patients describe racemic ketamine as opening a window for change, and integration work helps you walk through it. Innerwell includes preparation sessions and integration therapy to translate insights into lasting improvement.
- At-home comfort. Treatment happens in your own space—no clinic visits, no two-hour monitoring requirements, no disruption to your day.
- Insurance partnerships. Innerwell works with major insurers to bring costs down to $54 per treatment for covered patients.
Across thousands of at-home sessions, Innerwell patients report a 69% reduction in depression symptoms and a 60% reduction in anxiety symptoms after ten weeks.
Take our free assessment to see if racemic ketamine therapy might be right for you.
Frequently Asked Questions About Racemic Ketamine
Is racemic ketamine FDA-approved for depression?
Ketamine received FDA approval as an anesthetic in 1970. Its use for depression is off-label but legally prescribed by licensed clinicians based on decades of clinical research.
Is racemic ketamine the same as "Special K"?
Chemically, yes. But therapeutic use involves precise medical dosing, clinical supervision, and therapeutic integration—creating an entirely different risk profile.
Studies show that serious adverse effects like bladder toxicity are primarily linked to chronic, high-dose recreational patterns. In therapeutic settings, ketamine demonstrates a favorable short-term safety profile, though monitoring for blood pressure and dissociation remains important.
How does racemic ketamine compare to esketamine?
Racemic ketamine generally shows higher response rates in meta-analyses, likely because it contains both enantiomers. Esketamine offers FDA approval and potential insurance coverage but requires in-clinic administration. Individual responses vary.
Does racemic ketamine help with anxiety?
Treatment-resistant depression has the strongest evidence, but real-world data shows meaningful anxiety reductions in many patients. One study reported roughly 50% reductions in anxiety scores over several weeks.
How long do the effects last?
Effects typically last days to about a week after each session. Most patients continue with periodic maintenance sessions to sustain improvements.
Will racemic ketamine show up on a drug test?
Standard workplace drug tests don't screen for ketamine. Specialized tests can detect it if specifically requested. For more details, see our guide on ketamine and drug tests.
87% of Innerwell patients report improvement within 4 weeks
At-home treatment — no clinic visits
1/4th of the price compared to offline clinics
Led by licensed psychiatrists and therapists specialized in therapy
Insurance accepted in selected states
